Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2025-12-26 @ 3:45 PM
Study NCT ID:
NCT02174432
Status:
COMPLETED
Last Update Posted:
2025-05-21
First Post:
2014-06-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis
Sponsor:
Trevi Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08-15
Start Date Type:
ACTUAL
Primary Completion Date:
2017-09-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-03
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-24
First Submit QC Date:
None
Study First Post Date:
2014-06-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-08-06
Results First Submit QC Date:
None
Results First Post Date:
2020-10-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-08-28
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-05-19
Last Update Post Date:
2025-05-21
Last Update Post Date Type:
ACTUAL